{"id":"therapeutic-hydrocortisone","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Adrenal insufficiency"},{"rate":"5-10%","effect":"Glucose intolerance"},{"rate":"5-10%","effect":"Hypokalemia"},{"rate":"10-20%","effect":"Fluid retention"},{"rate":"10-20%","effect":"Hypertension"},{"rate":"5-10%","effect":"Osteoporosis"},{"rate":"<1%","effect":"Cushing's syndrome"},{"rate":"<1%","effect":"Growth suppression in children"},{"rate":"<1%","effect":"Psychiatric disturbances (e.g. anxiety, depression)"},{"rate":"<1%","effect":"Increased risk of infections"}]},"_chembl":{"chemblId":"CHEMBL2106309","moleculeType":"Small molecule","molecularWeight":"460.57"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Therapeutic hydrocortisone works by binding to the glucocorticoid receptor, which then translocates to the nucleus and regulates the expression of genes involved in inflammation. This leads to a decrease in the production of pro-inflammatory cytokines, such as IL-1 and TNF-alpha, and an increase in the production of anti-inflammatory cytokines, such as IL-10.","oneSentence":"Therapeutic hydrocortisone is a corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:54:04.301Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe asthma exacerbations"},{"name":"Severe allergic reactions (anaphylaxis)"},{"name":"Severe skin conditions (e.g. psoriasis, eczema)"},{"name":"Severe inflammatory conditions (e.g. rheumatoid arthritis, lupus)"}]},"trialDetails":[{"nctId":"NCT04759586","phase":"PHASE3","title":"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-05","conditions":"Primary Mediastinal Large B-Cell Lymphoma","enrollment":244},{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome","enrollment":6720},{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT07498465","phase":"PHASE1","title":"A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-09-10","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia","enrollment":29},{"nctId":"NCT07033039","phase":"NA","title":"Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2026-01-30","conditions":"Rhinoplasty, Edema","enrollment":60},{"nctId":"NCT06136650","phase":"PHASE3","title":"A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-18","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms","enrollment":1314},{"nctId":"NCT07462390","phase":"NA","title":"Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy","status":"WITHDRAWN","sponsor":"Tarsus University","startDate":"2026-03-03","conditions":"TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY","enrollment":""},{"nctId":"NCT06998121","phase":"NA","title":"The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate Biopsy","status":"RECRUITING","sponsor":"Mersin University","startDate":"2025-06-01","conditions":"Prostate Cancer","enrollment":84},{"nctId":"NCT00156767","phase":"","title":"Adrenal Function in Critical Illness","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2004-11-12","conditions":"Adrenal Insufficiency","enrollment":225},{"nctId":"NCT06136624","phase":"PHASE3","title":"Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-31","conditions":"Prostate Cancer Metastatic","enrollment":1310},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT06136598","phase":"PHASE1","title":"A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-01-30","conditions":"Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer","enrollment":14},{"nctId":"NCT06892197","phase":"PHASE4","title":"Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)","status":"RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2026-03-10","conditions":"Community Acquired Pneumonia (CAP)","enrollment":1600},{"nctId":"NCT06892210","phase":"PHASE4","title":"Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)","status":"RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2026-03-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":2000},{"nctId":"NCT05423613","phase":"NA","title":"Microneedling for Burn Hypertrophic Scars","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-01-22","conditions":"Burn Scar","enrollment":36},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT07472387","phase":"NA","title":"Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Glioblastoma (GBM)","enrollment":40},{"nctId":"NCT06124157","phase":"PHASE3","title":"A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-05-30","conditions":"B Acute Lymphoblastic Leukemia","enrollment":222},{"nctId":"NCT07468760","phase":"NA","title":"Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration Versus Early Implant Placement in the Esthetic Zone","status":"NOT_YET_RECRUITING","sponsor":"Gulf Medical University","startDate":"2026-03-30","conditions":"Tooth Loss in the Anterior Maxilla, Alveolar Bone Resorption, Partial Edentulism of the Maxilla","enrollment":42},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT07460154","phase":"NA","title":"Structured Review: To Optimise Management and Prevent Harm in COPD","status":"NOT_YET_RECRUITING","sponsor":"Northumbria Healthcare NHS Foundation Trust","startDate":"2026-03-01","conditions":"COPD","enrollment":96},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT03959085","phase":"PHASE3","title":"Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2019-10-31","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia","enrollment":5951},{"nctId":"NCT06979596","phase":"PHASE2","title":"A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-08-11","conditions":"Malignant Neoplasm","enrollment":250},{"nctId":"NCT06104449","phase":"PHASE1","title":"A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-14","conditions":"Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer","enrollment":6},{"nctId":"NCT07247058","phase":"PHASE4","title":"Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-02","conditions":"Mild Autonomous Cortisol Secretion (MACS)","enrollment":10},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT07451886","phase":"PHASE2","title":"Adjunctive Fludrocortisone in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-04-01","conditions":"Sepsis, Septic Shock, Sepsis - to Reduce Mortality in the Intensive Care Unit","enrollment":32},{"nctId":"NCT05431348","phase":"","title":"Effect of stRess and exeRcize on the Outcome After Chemo-Radiation","status":"COMPLETED","sponsor":"Maastricht Radiation Oncology","startDate":"2022-06-01","conditions":"Glioblastoma (GBM)","enrollment":42},{"nctId":"NCT06524895","phase":"NA","title":"Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2022-11-09","conditions":"Breast Cancer","enrollment":32},{"nctId":"NCT06177067","phase":"PHASE1","title":"Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-04-19","conditions":"Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage","enrollment":24},{"nctId":"NCT07383103","phase":"PHASE4","title":"Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-03-02","conditions":"Septic Shock","enrollment":336},{"nctId":"NCT07447024","phase":"NA","title":"Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-02","conditions":"Mastectomy","enrollment":60},{"nctId":"NCT07445594","phase":"NA","title":"Effect of Play Dough, Slime, and Plush Toys on Dental Anxiety and Pain in Children During Dental Treatment","status":"NOT_YET_RECRUITING","sponsor":"Afyonkarahisar Health Sciences University","startDate":"2026-02-17","conditions":"Dental Anxiety, Dental Pain, Behavioral Management","enrollment":90},{"nctId":"NCT06556277","phase":"NA","title":"Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2024-09-01","conditions":"Glucocorticoids, Overweight and Obesity, Overeating","enrollment":23},{"nctId":"NCT06289673","phase":"PHASE4","title":"Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-12-26","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia","enrollment":850},{"nctId":"NCT07443150","phase":"NA","title":"The Effect of BWSTT on Neuroendocrine Profile and Functional Recovery in Stroke Patients","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2017-07-03","conditions":"Stroke, Ischemic, Subacute Stroke","enrollment":40},{"nctId":"NCT06379074","phase":"NA","title":"Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health","status":"RECRUITING","sponsor":"University of Rome G. Marconi","startDate":"2024-05-06","conditions":"Postpartum Depression, Insomnia, Stress","enrollment":114},{"nctId":"NCT03742414","phase":"PHASE2","title":"Seal, Stopping Eczema and Allergy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kari Nadeau, MD, PhD","startDate":"2021-06-30","conditions":"Eczema, Infantile, Eczema, Atopic Dermatitis Eczema","enrollment":398},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT06390319","phase":"PHASE2","title":"Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-12-27","conditions":"T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, Mixed Phenotype Acute Leukemia","enrollment":100},{"nctId":"NCT06942039","phase":"EARLY_PHASE1","title":"Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation","status":"RECRUITING","sponsor":"C17 Council","startDate":"2025-09-23","conditions":"CNS Embryonal Tumor, CNS, Medulloblastoma, Atypical Teratoid Rhabdoid Tumor","enrollment":15},{"nctId":"NCT04293562","phase":"PHASE3","title":"A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-07-21","conditions":"Acute Myeloid Leukemia","enrollment":1186},{"nctId":"NCT06247787","phase":"PHASE1","title":"A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-02-04","conditions":"Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome, Recurrent Juvenile Myelomonocytic Leukemia","enrollment":36},{"nctId":"NCT05451264","phase":"NA","title":"Study of the Effect of Hydrocortisone Administered for the Prevention of Pulmonary Bronchodysplasia (PREMILOC Trial) on the Determinants of Systemic Blood Pressure in Children (PREMILOCAP)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-23","conditions":"Infant, Premature, Diseases","enrollment":52},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT06987786","phase":"NA","title":"Differences in Mechanistic Measures (Oxytocin and Cortisol) of Therapeutic Alliance Between A Talk-Based Therapy and Soft-Tissue Mobilization in Individuals With Chronic Spinal Pain","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-06-01","conditions":"Spine, Low Back Pain, Neck Pain","enrollment":25},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT05436535","phase":"PHASE4","title":"Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-11-21","conditions":"Atopic Dermatitis","enrollment":433},{"nctId":"NCT03604198","phase":"PHASE2","title":"Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corcept Therapeutics","startDate":"2018-05-07","conditions":"Cushing Syndrome","enrollment":125},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT05160506","phase":"PHASE2","title":"Corticosteroids to Treat Pancreatitis","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2022-03-06","conditions":"Pancreatitis, Pancreatitis, Acute, Corticosteroid","enrollment":86},{"nctId":"NCT07417371","phase":"NA","title":"Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway","status":"NOT_YET_RECRUITING","sponsor":"Dongdong Qin","startDate":"2026-04","conditions":"Tourette Syndrome in Children","enrollment":60},{"nctId":"NCT00400946","phase":"PHASE3","title":"05-001: Treatment of Acute Lymphoblastic Leukemia in Children","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2005-04","conditions":"Drug/Agent Toxicity by Tissue/Organ, Leukemia","enrollment":800},{"nctId":"NCT05436639","phase":"PHASE2","title":"SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2023-07-01","conditions":"Autonomous Cortisol Secretion (ACS), ACTH-Independent Cushing Syndrome, ACTH-Independent Adrenal Cushing Syndrome, Somatic","enrollment":30},{"nctId":"NCT06533748","phase":"PHASE2","title":"Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-01-23","conditions":"Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":128},{"nctId":"NCT03913559","phase":"PHASE2","title":"Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-05-14","conditions":"Acute Lymphoblastic Leukemia","enrollment":5},{"nctId":"NCT07104812","phase":"PHASE2","title":"Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-14","conditions":"Mild Autonomous Cortisol Secretion, Autonomous Cortisol Secretion (ACS)","enrollment":15},{"nctId":"NCT07389148","phase":"","title":"Salivary Cortisol Levels in Children With Molar Incisor Hypomineralization","status":"RECRUITING","sponsor":"Lokman Hekim University","startDate":"2026-01-26","conditions":"Molar Incisor Hypomineralization","enrollment":90},{"nctId":"NCT04488757","phase":"NA","title":"Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-11-04","conditions":"Chronic Widespread Pain, Stress, Psychological, Stress, Physiological","enrollment":70},{"nctId":"NCT06833437","phase":"NA","title":"68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)","status":"RECRUITING","sponsor":"Qifu Li","startDate":"2024-08-01","conditions":"Primary Aldosteronism, Autonomous Cortisol Secretion","enrollment":178},{"nctId":"NCT05299554","phase":"PHASE3","title":"Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"Neurocrine UK Limited","startDate":"2022-04-01","conditions":"Congenital Adrenal Hyperplasia","enrollment":76},{"nctId":"NCT07387926","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-03-26","conditions":"Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","enrollment":50},{"nctId":"NCT05656248","phase":"PHASE2","title":"Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2023-01-17","conditions":"Myeloid Neoplasm","enrollment":25},{"nctId":"NCT06895473","phase":"PHASE2","title":"Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2025-06-04","conditions":"Hematopoietic and Lymphatic System Neoplasm","enrollment":26},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT03164057","phase":"PHASE2","title":"A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-06-15","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes","enrollment":206},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT06638450","phase":"NA","title":"Clinical Trial for Acupuncture in Adolescents With Psychological Distress and Insomnia","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-03","conditions":"Psychological Distress, Insomnia","enrollment":148},{"nctId":"NCT04898894","phase":"PHASE1","title":"Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2021-11-15","conditions":"Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Refractory Acute Leukemia of Ambiguous Lineage","enrollment":37},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT06954441","phase":"PHASE3","title":"V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency","status":"RECRUITING","sponsor":"On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.","startDate":"2025-08-15","conditions":"Immunodeficiencies, Primary Immunodeficiencies (PID), Agammaglobulinemia","enrollment":50},{"nctId":"NCT07337512","phase":"NA","title":"Moringa Oleifera and Phoenix Dactylifera L. Effects on Cortisol and Breast Milk in Postpartum Depression","status":"COMPLETED","sponsor":"Melania Asi","startDate":"2024-05-19","conditions":"Postpartum Depression (PPD)","enrollment":363},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT06283693","phase":"NA","title":"The Effect of Mindfulness-based Stress Reduction Programme Given to Infertile Women","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-04-20","conditions":"Depression Anxiety Disorder, Demography, Family, Awakening Early","enrollment":84},{"nctId":"NCT04943289","phase":"PHASE1","title":"Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Joanne Kurtzberg, MD","startDate":"2021-01-24","conditions":"Primary Progressive Multiple Sclerosis","enrollment":20},{"nctId":"NCT06217939","phase":"NA","title":"Early Intravenous Hydrocortisone in Sepsis","status":"RECRUITING","sponsor":"Siriraj Hospital","startDate":"2024-06-25","conditions":"Sepsis Severe, Shock, Septic","enrollment":230},{"nctId":"NCT07313670","phase":"NA","title":"Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Aamir Latif","startDate":"2026-01-01","conditions":"Septic Shock","enrollment":122},{"nctId":"NCT07072585","phase":"PHASE2, PHASE3","title":"Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-28","conditions":"Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma","enrollment":1708},{"nctId":"NCT04231708","phase":"PHASE2","title":"Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Wayne State University","startDate":"2026-10","conditions":"Opioid Use Disorder","enrollment":20},{"nctId":"NCT06842316","phase":"","title":"Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-04-10","conditions":"Inflammatory Disorder of Immune System, Spondylitis, Ankylosing, Arthritis, Rheumatoid","enrollment":100},{"nctId":"NCT00097474","phase":"PHASE2","title":"Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2004-12-21","conditions":"Jet Lag","enrollment":57},{"nctId":"NCT07187011","phase":"PHASE2","title":"Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans","status":"NOT_YET_RECRUITING","sponsor":"San Diego Veterans Healthcare System","startDate":"2026-04-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":120},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT05193396","phase":"PHASE4","title":"Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment","status":"RECRUITING","sponsor":"Marianne Andersen","startDate":"2022-02-01","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)","enrollment":100},{"nctId":"NCT05761171","phase":"PHASE2","title":"A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-01-08","conditions":"Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage","enrollment":78},{"nctId":"NCT05453162","phase":"NA","title":"Circadian Influence on Prolonged Exposure Therapy for PTSD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-07-01","conditions":"PTSD","enrollment":52},{"nctId":"NCT02517489","phase":"PHASE3","title":"Community-Acquired Pneumonia : Evaluation of Corticosteroids","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2015-10-28","conditions":"Community Acquired Pneumonia","enrollment":952},{"nctId":"NCT07262957","phase":"PHASE4","title":"Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-09-01","conditions":"Pancreas Head Cancer, Pancreas Adenocarcinoma, IPMN, Pancreatic","enrollment":400},{"nctId":"NCT06336356","phase":"PHASE2","title":"A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-06-10","conditions":"Uncontrolled Hypertension","enrollment":48},{"nctId":"NCT03896659","phase":"PHASE4","title":"Exploring the Effects of Corticosteroids on the Human Hippocampus","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-10-01","conditions":"Hydrocortisone, Depression, Healthy Volunteers","enrollment":66},{"nctId":"NCT06409364","phase":"PHASE2","title":"FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-08-13","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":524},{"nctId":"NCT02553460","phase":"PHASE1, PHASE2","title":"Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2016-01-29","conditions":"Acute Lymphoblastic Leukemia","enrollment":50},{"nctId":"NCT07274501","phase":"NA","title":"The Effect of Music That the Individuals With Moderate Dental Anxiety Have Started Listening to While Waiting","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karadeniz Technical University","startDate":"2025-04-17","conditions":"Dental Anxiety","enrollment":90},{"nctId":"NCT02101853","phase":"PHASE3","title":"Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-17","conditions":"Recurrent B Acute Lymphoblastic Leukemia","enrollment":669},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":"Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","enrollment":847}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Aeroseb-HC","Barseb HC","Cetacort","Cort-Dome","Cortef"],"phase":"phase_3","status":"active","brandName":"therapeutic hydrocortisone","genericName":"therapeutic hydrocortisone","companyName":"AIDS Malignancy Consortium","companyId":"aids-malignancy-consortium","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Therapeutic hydrocortisone is a glucocorticoid receptor agonist, classified as a small molecule drug. It has been studied in various clinical trials for conditions such as sepsis, acute respiratory failure, and kidney transplant recipient immunosuppression.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1952-12-15T00:00:00.000Z","mah":"PHARMACIA AND UPJOHN","brand_name_local":"CORTEF","application_number":"NDA008697"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1955-05-10T00:00:00.000Z","mah":"PHARMACIA AND UPJOHN","brand_name_local":"CORTEF","application_number":"NDA009900"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1971-12-22T00:00:00.000Z","mah":"BAUSCH","brand_name_local":"CETACORT","application_number":"ANDA080426"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PHARMACIA AND UPJOHN","brand_name_local":"CORTEF","application_number":"NDA009864"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"ALLERGAN HERBERT","brand_name_local":"AEROSEB-HC","application_number":"ANDA085805"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"BAYER PHARMS","brand_name_local":"CORT-DOME","application_number":"NDA009585"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"BAYER PHARMS","brand_name_local":"CORT-DOME","application_number":"NDA009895"}],"trialStats":{"total":3,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}